Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

Scientists have discovered a wild new method that could protect astronauts from the copious amounts of space radiation they'd ...

A new review article published in Genes & Diseases explores the intricate relationship between non-coding RNAs and oxidative stress in cancer progression shedding new light on the mechanisms that ...

The CDC has sequenced bird flu viruses from people in Nevada and Wyoming, and the Trump Administration has released a ...

The mRNA vaccines that helped to end the COVID pandemic — and stoked a considerable amount of vaccine skepticism and ...

A bill banning gene-based vaccines, like some forms of the COVID-19 vaccine, received approval from a Senate subcommittee Monday.

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the retirement of Dr. Phillip A. Sharp, Ph.D., from the Company’s Board of Directors, effective as ...

Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following surgery in a small, early trial were still alive, most without disease ...

U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

This protein from tardigrades may hold the key to protecting healthy tissues during cancer radiation treatment.

Drugs in late-stage development may mean competition on price for two Pfizer medications that, by some accounts, are the most expensive cardiac medications in history.